Drugs News and Research

RSS

New York Times examines opposition to proposed off-label promotion guidelines amid allegations of ghostwriting

The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.

21 Apr 2008

New York Times examines increasing prices of specialty drugs distributed exclusively by pharmacy benefit managers

The New York Times on Saturday examined how pharmacy benefit managers in recent years "have built lucrative side businesses ... acting as exclusive or semi-exclusive distributors of expensive specialty drugs."

21 Apr 2008

South Carolina House to consider bill that would eliminate requirement to inform school officials of students' HIV-positive status

The South Carolina House this week is scheduled to consider a bill (SB 970) that would eliminate a state law that requires the Department of Health and Environmental Control to notify school district superintendents and nurses if students test HIV-positive, the Columbia State reports.

21 Apr 2008

Daily Star examines antiretroviral access in Bangladesh

Bangladesh's Daily Star on Friday examined how most people living with HIV/AIDS in the country do not have access to antiretroviral drugs. According to the Star, the country's Essential Drugs Company does not manufacture or provide antiretrovirals to Bangladesh's only infectious diseases hospital because of the drugs' high cost.

21 Apr 2008

Theranostics Health to commercialize microdissection technology from NIH

Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.

21 Apr 2008

MaxCyte introduces large scale transfection technology - accelerates cell-based assay development

MaxCyte has announced the introduction of its ITF Inline Transfection System, a validated platform for preparative transfection, based on unique flow electroporation technology.

21 Apr 2008

Children with attention deficit hyperactivity disorder should undergo heart tests before treatment with stimulant drugs

Children with attention deficit hyperactivity disorder (ADHD) should get careful cardiac evaluation and monitoring - including an electrocardiogram (ECG) - before treatment with stimulant drugs, a new American Heart Association statement recommends.

21 Apr 2008

Gene mutation helps protect against malaria

New research suggests that not everyone who is bitten by a malaria-infected mosquito develops life threatening health problems according to scientists at the University of Toronto.

21 Apr 2008

First comprehensive look at treatment practices for nonepileptic seizures

A new nationwide clinician survey provides the first comprehensive look at what is community care or 'treatment as usual' for nonepileptic seizures (NES), laying the groundwork for clinical trials aimed at identifying effective treatments for this neuropsychiatric disorder.

21 Apr 2008

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.

21 Apr 2008

Can IT fuel the race to the $1,000 human genome?

Ever wonder if you have a genetic disposition to a certain disease, or why a medicine works for your friend, but not for you?

21 Apr 2008

The limits of observational data in determining outcomes from cancer therapy

Certain biases may exist in observational studies that compare outcomes of different cancer therapies, making the results questionable.

21 Apr 2008

New method for testing treatments for Chagas' disease

Chagas' disease is a tropical parasitic sickness that currently affects more than 16 million people, with a staggering 100 million at risk, largely in the tropical areas of South and Central America. And yet the main drug used to treat the disease is highly toxic and causes serious side effects.

20 Apr 2008

GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure

About 40 percent of African-Americans have a genetic variant that can protect them after heart failure and prolong their lives, according to research conducted at Washington University School of Medicine in St. Louis and collaborating institutions.

20 Apr 2008

Social networking, malaria and philanthropy partnership

Philanthropy just got easier and a lot more accessible to the public thanks to the social networking power of the Internet and a ground-breaking partnership between a young British entrepreneur, a global health think tank and an African medical research institute.

20 Apr 2008

A genetic variation mimics effect of heart failure medications - may explain why beta-blockers do not work for all patients

A genetic variation, found predominantly in African Americans, protects some people with heart failure, enabling them to live longer than expected. That's the conclusion of a research team led by investigators at the University of Maryland School of Medicine in Baltimore and the Washington University School of Medicine in St. Louis.

20 Apr 2008

Hypertension all about what you eat and drink

Scientific research on human metabolism based on people from around the world has revealed compounds in urine indicate surprising differences affecting blood pressure.

20 Apr 2008

Pharmaceutical Care Management Association response to New York Times article on biotech medicine costs

The Pharmaceutical Care Management Association (PCMA) issued the following statement today regarding a story to be published in tomorrow's New York Times.

18 Apr 2008

Drug company coalition to push for looser rules on off-label marketing

Representatives of health care marketing firms, patient advocacy groups and pharmaceutical companies this week are in Washington, D.C., to express support for loosening rules regarding drug companies' ability to market medications for off-label uses, the Wall Street Journal reports (Mundy, Wall Street Journal, 4/18).

18 Apr 2008

Fluorine-based nanoparticles on track to improve cancer detection and therapy

Perfluorocarbons, a class of inert, oily polymers, have a proven track record in a variety of clinical uses, including in contrast-enhanced ultrasound imaging and in eye surgery to correct a detached retina.

18 Apr 2008

Drugs News and Research

New York Times examines opposition to proposed off-label promotion guidelines amid allegations of ghostwriting

New York Times examines increasing prices of specialty drugs distributed exclusively by pharmacy benefit managers

South Carolina House to consider bill that would eliminate requirement to inform school officials of students' HIV-positive status

Daily Star examines antiretroviral access in Bangladesh

Theranostics Health to commercialize microdissection technology from NIH

MaxCyte introduces large scale transfection technology - accelerates cell-based assay development

Children with attention deficit hyperactivity disorder should undergo heart tests before treatment with stimulant drugs

Gene mutation helps protect against malaria

First comprehensive look at treatment practices for nonepileptic seizures

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Can IT fuel the race to the $1,000 human genome?

The limits of observational data in determining outcomes from cancer therapy

New method for testing treatments for Chagas' disease

GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure

Social networking, malaria and philanthropy partnership

A genetic variation mimics effect of heart failure medications - may explain why beta-blockers do not work for all patients

Hypertension all about what you eat and drink

Pharmaceutical Care Management Association response to New York Times article on biotech medicine costs

Drug company coalition to push for looser rules on off-label marketing

Fluorine-based nanoparticles on track to improve cancer detection and therapy

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News